Latest Daiichi Sankyo Stories
PRINCETON, N.J., Oct. 1, 2014 /PRNewswire/ -- Ranbaxy Laboratories Inc.
Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline TOKYO and SAN DIEGO, Sept. 28, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Ltd.
BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- Registry provides new insights into AF treatment decisions, including patients' quality
Daiichi Sankyo and Charleston Laboratories will collaborate on development and commercialization; Charleston will supply all products and retain an option to co-promote in the United States
Benicar Lawsuit News: According to the FDA, Benicar Is Associated With Severe Gastrointestinal Disorder Called Sprue-Like Enteropathy, Which Can Cause Chronic Diarrhea, Rapid Weight Loss, Vomiting,
Kristine Kraft of Schlichter, Bogard & Denton, LLP reports that a recent lawsuit alleges that the blood pressure medication Benicar® is linked to serious gastrointestinal injuries, such
Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.